Results 261 to 270 of about 86,432 (312)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

Emergency Medicine Clinics of North America, 1998
Implantable cardioverter defibrillators have proven to be an effective therapy for life-threatening ventricular arrhythmias. Given the ever-increasing number of patients who have these devices, increasing numbers of patients are likely to present to emergency departments with defibrillator-related problems. This article discusses normal device function,
C P, Shah, R K, Thakur, B, Xie, V K, Hoon   +3 more
openaire   +3 more sources

Implantable Cardioverter Defibrillator:

Journal of Cardiovascular Electrophysiology, 1993
Implantable Cardioverter Defibrillator. The Ventritex® Cadence® Model V‐100 Tiered Therapy Defibrillator is a third generation antitachyarrhythmia device currently completing clinical trials in the United States. The implantable pulse generator is capable of high energy detibrillation, low energy cardioversion, as well as antitachycardia and ...
E S, Fain, R A, Winkle
openaire   +4 more sources

The implantable cardioverter defibrillator

Hospital Medicine, 2002
The implantable cardioverter defibrillator is the optimal treatment for both primary and secondary prevention in patients with previous aborted sudden death and with life-threatening cardiac arrhythmias. This article will review the indications and the evidence supporting implantable cardioverter defibrillator use.
C A, Rinaldi, J S, Gill
openaire   +2 more sources

The subcutaneous implantable cardioverter-defibrillator in review.

American Heart Journal, 2019
The subcutaneous implantable cardioverter defibrillator (S-ICD) is a completely extrathoracic device that has recently been FDA approved for the prevention of sudden cardiac death in select populations.
Nicholas J Kamp, S. Al‐Khatib
semanticscholar   +1 more source

The implantable cardioverter defibrillator

The Lancet, 2001
Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk patients include those who have survived life-threatening arrhythmias, and individuals with cardiac diseases who are at risk for such arrhythmias, but are ...
M, Glikson, P A, Friedman
openaire   +2 more sources

Implantable Cardioverter–Defibrillators

New England Journal of Medicine, 2003
Most people do not survive out-of-hospital cardiac arrest, and those who do may have substantial long-term cognitive and motor impairment. ICDs may avert such events. This review discusses the mechanisms of ICDs, clinical studies of their effectiveness, and management issues.
openaire   +2 more sources

Automatic Implantable Cardioverter-Defibrillators

Emergency Medicine Clinics of North America, 1994
The AICD represents a major technologic advance for patients with life-threatening ventricular tachyarrhythmias in whom drug or surgical therapy is unsuccessful. A significant reduction in mortality in these patients is seen with AICD use. As the device becomes more widely available and more centers in the country become adept in its implantation and ...
D W, Munter, W A, DeLacey
openaire   +2 more sources

Automatic Implantable Cardioverter-defibrillators

Annual Review of Biomedical Engineering, 1999
▪ Abstract  Ventricular fibrillation, a loss of synchronus electrical activity in the heart which leads to hemodynamic collapse, is a leading cause of death. Because of the devastating personal and societal effects of this phenomenon, the automatic cardioverter-defibrillator has been developed for automatic detection and termination of the arrhythmia ...
W M, Smith, R E, Ideker
openaire   +2 more sources

Exploding Implantable Cardioverter Defibrillator

Journal of Cardiovascular Electrophysiology, 2001
Exploding Implantable Cardioverter Defibrillator. A 79‐year‐old man with a pectoral implantable cardioverter defibrillator (ICD) system underwent periodic defibrillation threshold testing 18 months after implant. Attempted delivery of a 15‐J shock caused a light flash above the pocket and a loud “pop.” High‐voltage lead impedance was < 20 Ω. Pocket
openaire   +2 more sources

Implantable cardioverter-defibrillator advances

Current Opinion in Cardiology, 1996
Significant advances in the basic science of implantable cardioverter-defibrillator therapy have led to improvements in defibrillation waveforms and in capacitor technology. Nonthoracotomy devices with biphasic waveforms can be implanted with a near 100% success rate.
R D, Lerman, D S, Cannom
openaire   +2 more sources